MS4A1 and diffuse large B-cell lymphoma: Treatment with 10 μg/ml Rituximab for 24 h downregulated CD20 expression in DLBCL cells (Fig. 1e–g) but there is no remarkable sign of apoptotic cell death (cleavage of PARP) in this settings (Fig. 1g).